| B |
|
BASAL EXPRESSION OF ENDOTHELIAL CELL PROTEIN C RECEPTOR IS REGULATED BY ENDOGENOUS ALDOSTERONE, PRODUCED VIA ALDOSTERONE SYNTHASE
|
| Ducros E., Mirshahi S., Leviel F., Berthaut A., Soria J., Mirshahi M. |
| |
|
BASELINE QUALTIY OF LIFE (QOL) IN HEMOPHILIA PATIENTS RECEIVING CARE AT U.S. CENTERS
|
| Byams V.R., Soucie J.M., Owens S., U.D.C. Project Investigators |
| |
|
BAYESIAN STATISTICAL MODELLING OF PATIENTS INR RECORDS USING REPEATED MEASURES MODELS AND INDIVIDUAL TIME SERIES
|
| Fitzmaurice D.A., Murray E., Hussain S., Holder R., Rosendaal F., van Leeuwen Y., Cannegieter S. |
| |
|
BCL-2 AND BCL-XL EXPRESSION IN HUMAN CHOLANGIOCARCINOMA CELLS
|
| Smith G.E.L., Clutterbuck R., Heward J., Hutchins R., Scully M., Kakkar A. |
| |
|
BEMIPARIN THROMBOPROPHYLAXIS IN ELDERLY MEDICAL PATIENTS: THE "ANCIANOS" STUDY
|
| Rodríguez-Mañas L., Gómez-Huelgas R., Monteagudo G., Maeso R., Gómez-Outes A., Martínez-González J. |
| |
|
BENEFICIAL EFFECT OF 1-YEAR OPTIMAL MEDICAL TREATMENT, INDEPENDENT OF ADDITIONAL PTA, ON INFLAMMATION IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE (PAD)
|
| Nylaende M., Kroese A., Morken B., Stranden E., Sandbaek G., Lindahl A., Arnesen H., Seljeflot I. |
| |
|
BENEFICIAL EFFECTS OF ANTIPLATELET DRUGS IN SEPSIS: FIRST DATA FROM A CLINICAL AND ANIMAL STUDY
|
| Lösche W., Winning J., Reichel J., Hamacher J., Eisenhut Y., Kohl M., Deigner H.P., Claus R.A., Bauer M. |
| |
|
BENEFICIAL EFFECTS OF DAILY OLIVE OIL CONSUMPTION IN THROMBOSIS. STUDIES IN NORMOLIPEMIC PIGS
|
| Casani L., Molins B., Badimon L. |
| |
|
BENEFIT OF FONDAPARINUX IN THE LONG-TERM PREVENTION OF ISCHEMIC EVENTS IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES IN THE OASIS-5 TRIAL
|
| Mehta S.R. |
| |
|
BENEFIT-RISK RATIO OF FONDAPARINUX IN DIABETIC PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION (STEMI): A SUBANALYSIS OF OASIS-6
|
| Peters R., Mehta S.R. |
| |
|
BENIGN OUTCOME OF OBJECTIVELY PROVEN SPONTANEOUS RECANALIZATION OF INTERNAL CAROTID ARTERY OCCLUSION: LONG-TERM FOLLOW UP
|
| Camporese G., Labropoulos N., Verlato F., Bernardi E., Salmistraro G., Kontothanassis D., Ragazzi R., Barban M., Dalla Pozza A., Andreozzi G.M. |
| |
|
BERNARD-SOULIER PLATELETS EXPOSE MORE PROCOAGULANT PHOSPHATIDYLSERINE (PS), WITH PAR1 AND PAR4 MEDIATING THE SYNERGISTIC EFFECT OF THROMBIN ON COLLAGEN-STIMULATED PS EXPRESSION
|
| Rand M.L., Wang H., Bang K.W.A., Teitel J., Blanchette V.S., Freedman J., Nurden A.T. |
| |
|
BETA 2 GLYCOPROTEIN I PROTECTS THROMBIN FROM INHIBITION BY HEPARIN COFACTOR II: LOSS OF ACTIVITY BY PROTEOLYTICALLY CLIPPED BETA 2 GLYCOPROTEIN I
|
| Rahgozar S., Giannakopoulos B., Yan X., Qi J., Gemmell R., Krilis S.A. |
| |
|
BETA1-TUBULIN Q43P POLYMORPHISM IS ASSOCIATED WITH A HIGHER INTRACEREBRAL HAEMORRHAGE OCCURRENCE IN MEN
|
| Navarro-Núñez L., Lozano M., Rivera J., Corral J., Roldán V., González-Conejero R., Iniesta J., Montaner J., Vicente V., Martínez C. |
| |
|
BETA-ADRENERGIC RECEPTORS MODULATION OF T-PA RELEASE VIA NO SYNTHASE-DEPENDENT PATHWAY IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS
|
| Giannarelli C., Virdis A., De Negri F., Ghiadoni L., Magagna A., Salvetti A., Taddei S. |
| |
|
BETAINE (TRIMETHYLGLYCINE), A NOVEL ORAL ANTICOAGULANT WITH COMBINED NITRIC OXIDE AND TISSUE FACTOR PATHWAY INHIBITOR RELEASE POTENTIAL. IMPLICATIONS IN THE MANAGEMENT OF VASCULAR DISEASES
|
| Iqbal O.M., Messadek J., Ennamany R., Fareed D., Hoppensteadt D., Fareed J. |
| |
|
BETA-N-ACETYLHEXOSAMINIDASE (BETA-HEX), A PLATELET LYSOSOMAL ENZYME, POTENTIATES THROMBIN-INDUCED PLATELET ACTIVATION BY ACTING ON GPV
|
| Rossi R., Giannini S., Mencarelli S., Falcinelli E., Emiliani C., Gresele P. |
| |
|
B-GROUP VITAMINS' PROFILE AND OCCURRENCE OF CORONARY ARTERY DISEASE: A CASE-CONTROL STUDY
|
| Sofi F., Gori A., Marcucci R., Lucarini L., Rogolino A., Romano E., Del Pace S., Casini A., Abbate R., Gensini G. |
| |
|
BILATERAL THROMBOSIS OF POSTERIOR SHORT CILIORETINAL VESSELS IN A PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, HYPERHOMOCYSTEINE AND ETEROZIGOUS FOR MTHRF
|
| Giannarelli C., Figus M., De Negri F., Taddei S., Nardi M. |
| |
|
BILLIARY CIRRHOSIS: CONFORMATIONAL EFFECTS AND CONSEQUENCES OF THE OXIDATION OF HEPATIC SERPINS
|
| Hernandez-Espinosa D., Alcaraz A., Miñano A., Mota R., Ordoñez A., Garcia-Estañ J., Vicente V., Ortiz M., Corral J. |
| |
|
BIOCHEMICAL ANALYSIS OF RECOMBINANT FIBRINOGEN AALPHAGLN328PRO; PREVIOUSLY REPORTED AS FIBRINOGEN VARIANT SEOUL II WITH IMPAIRED FIBRIN ALPHA-CHAIN CROSS-LINKING
|
| Park R., Hong S., Shin J., Doh H., Choi J. |
| |
|
BIOCHEMICAL AND BIOPHYSICAL CHARACTERIZATION OF AN EXTREMELY STABLE TAFI VARIANT
|
| Ceresa E., Peeters M., Engelborghs Y., Declerck P., Gils A. |
| |
|
BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF A RVWF DRUG CANDIDATE PRODUCED UNDER SERUM-FREE CONDITIONS
|
| Turecek P.L., Mitterer A., Matthiessen H.P., Gritsch H., Váradi K., Plaimauer B., Purtscher M., Woehrer W., Muchitsch E.M., Schwarz H.P. |
| |
|
BIOCHEMICAL AND FUNCTIONAL CHARACTERIZATION OF CHEMICALLY MODIFIED RECOMBINANT VON WILLEBRAND FACTOR (RVWF) AS A CARRIER PROLONGING SURVIVAL OF RFVIII IN HEMOPHILIA A KNOCK-OUT MICE
|
| Turecek P.L., Scheiflinger F., Siekmann J., Váradi K., Matthiessen H.P., Weber A., Gritsch H., Muchitsch E.M., Baumgartner B., Schwarz H.P. |
| |
|
BIOCHEMICAL AND MECHANICAL PROPERTIES OF INTRALUMINAL THROMBUS FROM HUMAN ABDOMINAL AORTIC ANEURYSM
|
| Camera M., Ballerio R., Spirito R., Di Martino E., Tremoli E., Boschetti F. |
| |
|
BIOCHEMICAL AND PHARMACOLOGICAL PROPERTIES OF KDN-7438, A NOVEL SYNTHETIC TISSUE FACTOR/FACTOR VIIA INHIBITOR
|
| Moritani Y., Shigenaga T., Sakata C., Ishihara T., Miura M., Kawasaki T., Homma T., Matsuzawa A., Hirabayashi A. |
| |
|
BIOCHEMICAL CHARACTERISATION OF ANTITHROMBIN BUDAPEST 3 (L99F)
|
| Langdown J.V., Baglin T.P., Huntington J.A. |
| |
|
BIOEQUIPOTENCY OF IDRAPARINUX AND BIOTINYLATED IDRAPARINUX AFTER SINGLE DOSE IN HEALTHY SUBJECTS
|
| Trellu M., Perez Y., Ortiz J., Cheng S., Paty I. |
| |
|
BIOLOGICAL ACTIVITY OF PEGYLATED FACTOR VIII
|
| Regan L., Jiang X., Ramsey P., Severs J., Sompalli S., Samuels N., Teare J., Tollner A., Tang L. |
| |
|
BIOLOGICAL AND CLINICAL RESPONSE TO DESMOPRESSIN IN CHILDREN WITH VON WILLEBRAND DISEASE
|
| Sánchez-Luceros A., Meschengieser S.S., Turdó K., Woods A.I., Kempfer A.C., Blanco A.N., Lazzari M.A. |
| |
|
BIOLOGICAL ASSAY OF ASPIRIN-RESISTANCE: ULTRASTRUCTURE OF PLATELET GLYCOPROTEIN REDISTRIBUTION AFTER ARACHIDONIC ACID ACTIVATION AND ASPIRIN INHIBITION, AND COMPARISON WITH USUAL LABORATORY TESTS
|
| Flaujac C., Duval-Deverloy A., Momeux L., Luneau S., Deschamps A., Cramer-Bordé E. |
| |
|
BIOLOGICAL INHIBITION OF PLATELET PROSTAGLANDIN PATHWAY IS NOT MAINTAINED BY LOW DOSE ASPIRIN THROUGHOUT 24 HOURS IN TYPE 2 DIABETIC PATIENTS
|
| Guyetand C., Belluci S., Sideris G., Boval B., Sirol M., Henry P., Drouet L. |
| |
|
BIOMARKER ANALYSIS BY FLUOROKINE MULTI-ANALYTE PROFILING DISTINGUISHES PATIENTS REQUIRING INTERVENTION FROM PATIENTS WITH LONG-TERM QUIESCENT CORONARY ARTERY DISEASE: A POTENTIAL APPROACH TO IDENTIFY ATHEROSCLEROTIC DISEASE PROGRESSION
|
| Gurbel P.A., Bliden K.P., Kreutz R.P., DiChiara J., Tantry U.S. |
| |
|
BIOMECHANICAL PROPERTIES OF VON WILLEBRAND FACTOR BINDING TO PLATELET GLYCOPROTEIN IB RECAPITULATED BY THE DIMERIC A1 DOMAIN
|
| Orje J.N., Machin M., Roberts J.R., McClintock R.A., Habermann R., Canu P., Ruggeri Z.M. |
| |
|
BISBUDIAME, AN ESTROGEN DERIVATIVE WITH AN ANTITHROMBOTIC EFFECT
|
| de la Peña A., Gonzalez-Alva C., Fernandez-G J., Pinzon E., Torres I., Bahena A., Mendoza G. |
| |
|
BIVALENT BINDING OF THROMBIN TO GAMMA'-FIBRIN ENHANCES PROTECTION FROM INHIBITION BY ANTITHROMBIN-HEPARIN
|
| Stafford A.R., Leslie B.A., Fredenburgh J.C., Weitz J.I. |
| |
|
BLEEDING AND THROMBOTIC COMPLICATIONS OF LIVER TRANSPLANTATION IN CHILDREN
|
| Monagle P., Ignjatovic V., Theo S., Bhat R., Hardikar W., Jones B. |
| |
|
BLEEDING AND THROMBOTIC MANIFESTATION IN 58 PATIENTS WITH CONGENITAL DYSFIBRINOGENEMIA
|
| Batorova A., Horvathova D., Jankovicova D., Mistrik M., de Moerloose P., Neerman-Arbez M. |
| |
|
BLEEDING COMPLICATIONS ASSOCIATED WITH PHARMACOLOGICAL PROPHYLAXIS FOR MAJOR ORTHOPAEDIC SURGERY
|
| Hitos K., Fletcher J.P. |
| |
|
BLEEDING COMPLICATIONS IN SURGICAL PATIENTS WITH VON WILLEBRAND'S DISEASE
|
| von Auer C., Lotter K., Scharrer I. |
| |
|
BLEEDING PATTERNS ON PROPHYLAXIS FOR SEVERE HAEMOPHILIA: WEEK DAY AND SEASONAL INFLUENCE
|
| Fischer K., Astermark J., Blanchette V., Bjorkman S., Collins P., Fritsch S., Oh M., Schroth P., Spotts G., Ewenstein B.M. |
| |
|
BLEEDING SCORE IS INCREASED IN AFFECTED RELATIVES WITH TYPE 1 VON WILLEBRAND DISEASE AND ABNORMAL MULTIMERIC PATTERN IDENTIFIED IN THE EU MCMDM-1 VWD STUDY
|
| Castaman G., Tosetto A., Rodeghiero F., Goodeve A., Federici A.B., Batlle J., Meyer D., Mazurier C., Goudemand J., Fressinaud E., Eikenboom J., Schneppenheim R., Budde U., Ingerslev J., Vorlova Z., Habart D., Holmberg L., Lethagen S., Pasi J., Hill F., Peake I. |
| |
|
BLOOD BORNE TISSUE FACTOR: CELLULAR LOCALIZATION AND SPECIFIC ACTIVITIES
|
| Østerud B., Olsen J. |
| |
|
BLOOD BORNE VIRUS INFECTIONS IN YOUNG HAEMOPHILIACS IN POLAND
|
| Windyga J., Grabarczyk P., Klukowska A., Buczma A., Laguna P., Stefanska E., Szczepanik A., Mikulska M., Brojer E. |
| |
|
BLOOD COAGULATION REACTIONS ON NANOSCALE MEMBRANE SURFACES
|
| Pureza V.S., Shaw A.W., Sligar S.G., Morrissey J.H. |
| |
|
BLOOD EOSINOPHILS STORE AND EXPOSE TISSUE FACTOR (TF) PROMOTION OF TRANSENDOTHELIAL MIGRATION
|
| Moosbauer C., Morgenstern E., Cuvelier S.L., Manukyan D., Bidzhekov K., Albrecht S., Patel K.D., Engelmann B. |
| |
|
BLOOD FLOW SUPPRESSES FEEDBACK ACTIVATION OF EXTRINSIC TENASE BY FACTOR XA AND PREVENTS CLOTTING
|
| Shibeko A.M., Avilov O.E., Panteleev M.A., Lobanova E.S., Ataullakhanov F.I. |
| |
|
BLOOD GROUP AB AND FV LEIDEN AS RISK FACTORS FOR PRE-ECLAMPSIA
|
| Hiltunen L.M., Laivuori H., Rautanen A., Kaaja R., Kere J., Krusius T., Paunio M., Rasi V. |
| |
|
BLOOD, PLATELET AND ENDOTHELIAL OSTEOPROTEGERIN EXPRESSION IN RELATION WITH ATHEROSCLEROTIC CALCIFICATION IN A MODEL OF GENETICALLY HYPERCHOLESTEROLEMIC PIGS
|
| Chollet M., Bal dit Sollier C., Brouland J., Bonneau M., Kang C., Berge N., Collet C., Drouet L. |
| |
|
BLOOD-BORNE BUT NOT ENDOTHELIAL CD40 PROMOTES EXPERIMENTAL LUNG METASTASIS
|
| Amirkhosravi A., Langer F., Ingersoll S.B., Robson T., Francis J.L. |
| |
|
BODY MASS INDEX, MILD HYPERHOMOCYSTEINEMIA AND VENOUS THROMBOEMBOLISM RISK
|
| Delluc A., Le Gal G., Lacut K., Couturaud F., Mottier D., Oger E.J. |
| |
|
BONE MARROW-DERIVED MONONUCLEAR CELL THERAPY INDUCES DISTAL ANGIOGENESIS AFTER LOCAL INJECTION IN CRITICAL LEG ISCHEMIA
|
| Duong Van Huyen J., Smadja D., Bruneval P., Gaussem P., Dal-Cortivo L., Julia P., Fiessinger J., Cavazzana-Calvo M., Aiach M., Emmerich J. |
| |
|
BRAIN NATRIURETIC PEPTIDE AS A PRECLINICAL MARKER OF CHRONIC PULMONARY HYPERTENSION IN PATIENTS WITH PULMONARY EMBOLISM
|
| Dentali F., Donadini M., Gianni M., Lonn E., Bertolini A., Venco A., Cattozzo G., Ageno W. |
| |
|
BREAKPOINT CHARACTERIZATION IN HEMOPHILIA PATIENTS WITH LARGE DELETIONS IN THE FVIII GENE REVEALS INVOLVEMENT OF VARIOUS MUTATION MECHANISMS
|
| Mühle C., Schröder J., Oldenburg J., Schneider H. |
| |
|
BREAKTHROUGH BLEEDING IN SEVERE HAEMOPHILIA A. DOES THE FVIII TROUGH LEVEL MATTER?
|
| Collins P., Astermark J., Blanchette V., Bjorkman S., Fischer K., Schroth P., Fritsch S., Oh M., Spotts G., Ewenstein B.M. |
| |
|
BRIDGING THERAPY IN PATIENTS TREATED WITH LMWH AND COUMARIN INDUCES DEEP INHIBITION OF THROMBIN GENERATION
|
| Gerotziafas G.T., Dupont C., Elalamy I., Verdy E. |
| |
|
BSDL INTERACTS WITH THE PLATELET CXCR4 AND MODULATES THROMBUS FORMATION
|
| Panicot-Dubois L., Furie B.C., Furie B., Lombardo D., Dubois C. |
| |
|
BUDD-CHIARI SYNDROME IN A PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENT WITH PREVIOUS CEREBRAL VENOUS THROMBOSIS
|
| Tufano A., Macarone Palmieri N., Cimino E., Somma C., Fiorica A., Cerbone A.M., Alfinito F., Di Minno G. |
| |
|
B-VITAMIN SUPPLEMENTATION LOWERS PLASMA HOMOCYSTEINE CONCENTRATION BUT DOES NOT AFFECT PLASMA METHIONINE AND CYSTEINE CONCENTRATIONS: A POSSIBLE EXPLANATION FOR NEGATIVE RESULTS OF CLINICAL TRIALS
|
| den Heijer M., Keijzer M., van Landeghem B.A.J., Blom H.J. |
| |
